| Systematic (IUPAC) name | |
|---|---|
| N-(2-[(2R)-2-[(dipropylamino)methyl]piperidin-1-yl]ethyl)-6-oxo-5H-pyrido[2,3-b][1,4]benzodiazepine-11-carboxamide | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 118290-27-0 |
| ATC code | ? |
| PubChem | CID 119357 |
| ChemSpider | 26233613 |
| Chemical data | |
| Formula | C27H38N6O2 |
| Mol. mass | 478.628 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
AFDX-384 (BIBN-161) is a drug which acts as a selective antagonist of the muscarinic acetylcholine receptors, with selectivity for the M2 and M4 subtypes. It is used mainly for mapping the distribution of M2 and M4 muscarinic receptors in the brain, and studying their involvement in the development and treatment of dementia and schizophrenia.[1][2][3][4][5][6][7]
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)